Open an account

WAVE Life Sciences

WVE · NASDAQ

$3.42+$0.25 (+7.89%)TodayMarket closed ·
Prev close $3.17

About WVE

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. The company employs 317 full-time employees The company went IPO on 2015-11-11. The Company’s RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing Wave with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company’s diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington’s disease, as well as several preclinical programs utilizing the Company’s broad RNA therapeutics toolkit. Its programs include WVE-006, SERPINA1 (AATD); WVE-007 (GalNAc), INHBE (Obesity); WVE-N531, Exon 53 (DMD), and WVE-003, mHTT (HD).

Employees
317
Headquarters
Singapore
Listed
Nov 11, 2015
Sector
Health Care
Industry
Pharmaceuticals
Website
wavelifesciences.com

WVE key statistics

Market cap
1.11B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
3.22M
Volume
3.19M
Open price
$3.18
High today
$3.49
Low today
$3.18
52 Week high
$21.73
52 Week low
$3.04

WAVE Life Sciences (WVE) at a glance

As of Oct 20, 2026, WAVE Life Sciences (WVE) shares are priced at $3.42, giving the company a market cap of 1.11B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $3.18 and $3.49. The current price is 7.5% above the day's low and 2.0% below its high.

Volume so far is 3.19M shares, in line with the average of 3.22M shares a day.

Over the past year WAVE Life Sciences has ranged from $3.04 to $21.73, and now sits 2% of the way up that range.

WAVE Life Sciences met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported -$0.34 per share against an estimate of -$0.3121.

The average analyst price target is $19.86, 480.7% above the current price, from 17 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

94%of 17 analyst ratings say Buy
  • Buy94.1%
  • Hold5.9%
  • Sell0.0%
Price target · 18 analystsAvg $19.86
Low
$12.12
Now
$3.42
High
$44.10

WVE earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 126.6% on average.

  1. Q3 FY24: reported -$0.47 per share against an estimate of -$0.2862
  2. Q4 FY24: reported $0.17 per share against an estimate of -$0.1838
  3. Q1 FY25: reported -$0.29 per share against an estimate of -$0.2635
  4. Q2 FY25: reported -$0.31 per share against an estimate of -$0.2935
  5. Q3 FY25: reported -$0.32 per share against an estimate of -$0.3013
  6. Q4 FY25: reported -$0.30 per share against an estimate of -$0.2728
  7. Q1 FY26: reported -$0.13 per share against an estimate of -$0.3311
  8. Q2 FY26: reported -$0.34 per share against an estimate of -$0.3121

WVE news

  • Press releasePRNewswire

    Eco Wave Power Featured for Second Time in NVIDIA Founder and CEO Jensen Huang's GTC Keynote, as Company Advances Taiwan Wave Energy Project

  • Press releaseGlobe Newswire

    Wave Life Sciences Ltd. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses

  • Press releasePRNewswire

    Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1

  • Press releaseGlobe Newswire

    Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition

  • 12 Health Care Stocks Moving In Thursday's Intraday Session

  • Avi Kapoor

    Crude Oil Gains 4%; Commercial Metals Posts Mixed Q2 Results

  • Vandana Singh

    Why Is Wave Life Sciences Stock Falling After Weight Loss Study Data?

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.